Q BioMed Announces Updates on Commercialization of Non-Opioid Metastatic Cancer Pain Drug NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is pleased to announce the latest updates on its non-opioid therapy for the debilitating...

Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA) NEW YORK, June 28, 2019 (GLOBE...